Chongqing Kangle Pharmaceutical Co Ltd | FDA | Inspections | Form 483 | Warning Letters

filter Legal Name

All (2)

01 Chongqing Kangle Pharmaceutical Co., Ltd (2)

filter District Decision

All (2)

01 Voluntary Action Indicated (2)

filter Inspection End Date

All (2)

01 2015-01-30 (1)

02 2012-04-26 (1)

filter City

All (2)

01 Chongqing (2)

filter Country/Area

All (2)

01 CN (2)

Details of Chongqing Kangle Pharmaceutical Co Ltd's U.S. FDA Inspections. Original Data: FDA Inspection Database

Chongqing Kangle Pharmaceutical

About

Contact Details

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

APIs // Active Pharmaceutical Ingredients

5 APIs

4 USDMF

2 CEP/COS

4 JDMF

3 KDMF

2 NDC API

DEVELOPMENTS

INSPECTIONS & REGISTRATIONS

2 FDA

Chongqing Kangle Pharmaceutical

INSPECTIONS & REGISTRATIONS

Voluntary Action Indicated

2012-04-26

Chongqing

CN

ORA

CDER

Drug Quality Assurance

INSPECTIONS & REGISTRATIONS

Voluntary Action Indicated

2015-01-30

Chongqing

CN

ORA

CDER

Drug Quality Assurance